The Turkish Version of Pain Coping Questionnaire

May 31, 2023 updated by: Ozgun Kaya Kara, Akdeniz University

The Turkish Adaptation, Validity, and Reliability Study of the Pain Coping Questionnaire

Biological, psychological, and social factors all influence a child's sense of pain. Pain beliefs can have a significant impact on a person's perception of pain and adherence to treatment. As a result, pain management requires a thorough examination of the factors that influence pain perception. Coping is a cognitive and behavioral response to conditions and threats based on by personal or environmental factors. Children who do not have adequate coping mechanisms suffer from more severe pain. As a result, dealing with pain is a crucial part of pain management. This highlights the need of assessing pain coping in children when treating chronic pain. The purpose of this study is to show that the Turkish version of the Pain Coping Questionnaire (PCQ), which assesses children's pain coping techniques, is valid and reliable, as well as to ensure that it is culturally appropriate.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Pain is a biopsychosocial term that comprises sensory, cognitive, and emotional factors. The biological, psychological, and cognitive aspects of pain are all present. Pain symptoms and comorbid symptoms are biological characteristics; anxiety, depression, and rage are psychological characteristics; and the ability to cope, catastrophize, and manage pain are cognitive characteristics. As a result, pain is influenced by a person's past experiences and beliefs. Pain that lasts longer than three months is referred to as chronic pain. A major issue is the high prevalence of chronic pain in children. Children with chronic pain have a lower quality of life than their healthy peers. Furthermore, this effect is unrelated to the degree of biological damage. Some children are more sensitive to pain than others, regardless of the severity of the condition. Because psychological, cognitive, and social variables influence an individual's perception of pain in addition to biological tissue damage.

The use of coping techniques in children varies based on the diagnosis, age, and gender of the child, according to the literature. Inadequate coping techniques are linked to a lower quality of life and increased pain severity. As a result, pain assessment in children with chronic pain should be done within a biopsychosocial framework. Various assessments have been developed to assess children's pain tolerating abilities. The Pain Coping Questionnaire (PCQ) was created to evaluate problem-focused, emotional-focused, and avoidance-focused coping strategies in children. It's the most commonly used scale for assessing children's coping techniques. The purpose of this study is to show that the Turkish version of the Pain Coping Questionnaire is valid and reliable (PCQ).

Study Type

Observational

Enrollment (Estimated)

330

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey
        • Akdeniz University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Children are diagnosed with chronic pain and their parents Children without chronic pain and their parents

Description

Inclusion Criteria:

  • Age between 6 years and 18 years;
  • Diagnosed with chronic pain.
  • To have the cognitive ability to answer questions for assessment.
  • Completing the test-retest assessment.
  • To be able to read and speak Turkish

Exclusion Criteria:

  • Patients with unmanageable psychological disorders (e.g., attention deficit hyperactivity disorder, autistic spectrum disorder, schizophrenia, bipolar disorder, major depressive disorder) would be excluded from the study.
  • Patients who started a new treatment during the trial or 6 weeks before to the study for chronic pain.
  • Those who take analgesics 48 hours prior to study evaluations

Inclusion Criteria for Healthy Children:

  • Healthy children aged 6-18 years old
  • Children without a psychiatric and neurological diagnosis

Exclusion Criteria for Healthy Children:

  • Children got medical treatment for a neuropsychiatric disorder
  • Children whose parents or themselves refused to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Chronic pain group
Children with chronic pain
Health group
children without chronic pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of coping strategies
Time Frame: Baseline
Pain Coping Questionnaire: Evaluates the coping strategies of children and adolescents with a total of 39 items in 8 subscale. These are seeking knowledge, problem solving, seeking social support, positive self-suggestion, behavioral distraction, cognitive distraction, externalization, and internalization/catastrophizing. Items are assessed on a 5-point Likert scale, with 1 indicating never and 5 indicating very often. Higher ratings indicate higher use of coping strategy. PCQ consists of parent and adolescent form.
Baseline
Evaluation of pain
Time Frame: Baseline
Wong baker faces pain scale: It is a valid and reliable scale preferred by children and their families to evaluate the severity of pain. It consists of 6 facial expressions that symbolize the severity of pain. These show the stages of increased pain from a smiling face (0 points) to a very sad and crying face (10 points). The meaning of each facial expression is carefully explained to the child. Children rate pain intensity according to face shapes.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of pain acceptance
Time Frame: Baseline
Pain Flexibility Scale for Children: The scale assesses children's pain acceptance in chronic pain.It has a total of 20 questions divided into two sub-sections: valued activities and pain resistance. Pain resistance examines pain avoidance and control, whereas valued behaviors assesses involvement in meaningful activities despite pain. The scale is a seven-point Likert scale, with 0 indicating total disagreement (never true), and 6 indicating total agreement (Always true).
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ozgun Kaya Kara, Assoc. Prof., Akdeniz University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2022

Primary Completion (Estimated)

August 8, 2023

Study Completion (Estimated)

August 12, 2023

Study Registration Dates

First Submitted

June 8, 2022

First Submitted That Met QC Criteria

June 14, 2022

First Posted (Actual)

June 16, 2022

Study Record Updates

Last Update Posted (Actual)

June 1, 2023

Last Update Submitted That Met QC Criteria

May 31, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-125

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The study result will be published to the journal

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe